Gut · 2004 · 239 citations · 50 references
Life SciencesInfectious DiseasesMicrobiologyBacteriologyGastroenterologyMedical MicrobiologyBacterial InfectionsGastrointestinal ImmunologyHelicobacter Pylori Eradication TherapyPeptic Ulcer DiseaseEradicationGastric HistologyGastric PathologyHelicobacter Pylori EradicationHelicobacter Pylori InfectionHelicobacter Pylori TestingUrea Breath Test
BACKGROUND: A reliable challenge model is needed to evaluate Helicobacter pylori vaccine candidates. METHODS: A cag pathogenicity island negative, OipA positive, multiple antibiotic susceptible strain of H pylori obtained from an individual with mild gastritis (Baylor strain 100) was used to challenge volunteers. Volunteers received 40 mg of famotidine at bedtime and 10(4)-10(10) cfu of H pylori in beef broth the next morning. Infection was confirmed by (13)C urea breath test ((13)C-UBT), culture, and histology. Eradication therapy was given four or 12 weeks post challenge and eradication was confirmed by at least two separate UBTs, as well as culture and histology. RESULTS: Twenty subjects (nine women and 11 men; aged 23-33 years) received a H pylori challenge. Eighteen (90%) became infected. Mild to moderate dyspeptic symptoms occurred, peaked between days 9 and 12, and resolved. Vomitus from one subject contained >10(3) viable/ml H pylori. By two weeks post challenge gastric histology showed typical chronic H pylori gastritis with intense acute and chronic inflammation. The density of H pylori (as assessed by cfu/biopsy) was similarly independent of the challenge dose. A minimal infectious dose was not found. Gastric mucosal interleukin 8 levels increased more than 20-fold by two weeks after the challenge. CONCLUSION: Challenge reliably resulted in H pylori infection. Infection was associated with typical H pylori gastritis with intense polymorphonuclear cell infiltration and interleukin 8 induction in gastric mucosa, despite absence of the cag pathogenicity island. Experimental H pylori infection is one of the viable approaches to evaluate vaccine candidates.
50
Stefano Censini, Christina Lange, Z Xiang et al. · Proceedings of the National Academy of Sciences · 1996 · 1.9K citations · Full text
Attempt to fulfil Koch's postulates for pyloric Campylobacter
Barry J. Marshall, John A. Armstrong, David B. McGechie et al. · The Medical Journal of Australia · 1985 · 1.3K citations
Experimental Campylobacter jejuni Infection in Humans
R.A. Black, Myron M. Levine, M L Clements et al. · The Journal of Infectious Diseases · 1988 · 1K citations